Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-03 Sale |
2021-02-03 8:04 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
2,516 | $74.69 | $187,920 | 20,854 (Direct) |
View |
| 2021-01-30 Sale |
2021-02-02 4:28 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
2,243 | $140.36 | $314,827 | 33,546 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-19 4:01 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
25,000 | $139.18 | $3,479,500 | 98,789 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-08 7:05 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
4,000 | $140.65 | $562,600 | 23,716 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 6:45 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
30,000 | $136.9 | $4,107,000 | 2,939,930 (Indirect Direct) |
View |
| 2020-12-08 Sale |
2020-12-10 4:55 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Ultragenyx Pharmaceutical Inc. Director 10% Owner |
800,000 | $100.81 | $80,650,635 | 2,200,000 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 3:44 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
30,000 | $96.82 | $2,904,600 | 2,969,930 (Indirect Direct) |
View |
| 2020-10-30 Sale |
2020-11-02 5:05 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
9,903 | $100.12 | $991,488 | 49,061 (Direct) |
View |
| 2020-10-28 Sale |
2020-10-30 5:28 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
97 | $100 | $9,700 | 58,871 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
262 | $88 | $23,056 | 35,789 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
325 | $88 | $28,600 | 23,968 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:20 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
262 | $87.98 | $23,051 | 101,478 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:20 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
220 | $88 | $19,360 | 23,370 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:19 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
262 | $88 | $23,056 | 46,299 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:18 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
262 | $88 | $23,056 | 34,699 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:16 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
146 | $87.98 | $12,845 | 16,436 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:15 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini EVP, Finance |
375 | $87.99 | $32,996 | 97,812 (Direct) |
View |
| 2020-10-12 Sale |
2020-10-13 5:55 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
2,780 | $94.47 | $262,627 | 46,561 (Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 5:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $95 | $950,000 | 59,293 (Direct) |
View |
| 2020-10-06 Sale |
2020-10-07 2:57 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $90 | $900,000 | 41,293 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-24 4:47 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $85 | $850,000 | 51,293 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-02 4:26 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
30,000 | $82.63 | $2,478,900 | 3,000,782 (Indirect Direct) |
View |
| 2020-08-21 Sale |
2020-08-25 3:56 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
5,000 | $86.57 | $432,850 | 147,510 (Indirect Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 2:12 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
12,370 | $88.43 | $1,093,884 | 69,293 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 2:11 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
14,378 | $88.4 | $1,271,073 | 129,311 (Direct) |
View |
| 2020-08-07 Sale |
2020-08-11 12:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
34,750 | $85.37 | $2,966,736 | 4,146 (Direct) |
View |
| 2020-07-13 Sale |
2020-07-15 1:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
40,000 | $85.35 | $3,414,000 | 3,030,782 (Indirect Direct) |
View |
| 2020-07-08 Sale |
2020-07-10 5:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,638 | $91 | $240,058 | 28,582 (Direct) |
View |
| 2020-07-06 Sale |
2020-07-08 12:30 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $90 | $556,290 | 13,550 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-06 2:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $85 | $425,000 | 19,731 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-06 2:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,611 | $81 | $211,491 | 31,220 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-05-22 Ownership |
2021-02-03 8:03 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
181,670 | $0 | 2,928,682 (Indirect) |
View |
| 2020-05-21 Ownership |
2021-02-03 8:02 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
2,000 | $0 | 146,510 (Direct) |
View |
Ownership |
2021-02-03 8:02 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
0 | $0 | 146,510 (Indirect) |
View |
| 2020-11-06 Ownership |
2021-02-03 8:01 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
934 | $0 | 15,502 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 4:01 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
25,000 | $55 | 98,789 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 4:01 pm |
N/A 2028-01-30 |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
25,000 | $0 | 98,789 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-08 7:05 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
4,000 | $21 | 23,716 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-08 7:05 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
4,000 | $0 | 23,716 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 5:05 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
9,903 | $0 | 49,061 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 5:05 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
9,903 | $54.5 | 49,061 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 5:28 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
97 | $0 | 58,871 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 5:28 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
97 | $54.5 | 58,871 (Direct) |
View |
Ownership |
2020-10-30 5:26 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Ultragenyx Pharmaceutical Inc. 10% Owner |
0 | $0 | 7,825,797 (Direct) |
View |
| 2020-10-14 Tax Withholding |
2020-10-16 7:23 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
852 | $92.69 | 2,999,930 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-13 5:53 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 59,293 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-13 5:53 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $54.5 | 59,293 (Direct) |
View |
| 2020-10-12 Option Award |
2020-10-13 5:52 pm |
N/A 2030-10-12 |
Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President |
40,000 | $0 | 80,000 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-07 2:57 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $48.43 | 41,293 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-07 2:57 pm |
N/A 2028-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 41,293 (Direct) |
View |
| 2020-09-23 Exercise |
2020-09-24 4:47 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $48.43 | 51,293 (Direct) |
View |
| 2020-09-23 Exercise |
2020-09-24 4:47 pm |
N/A 2028-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 51,293 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 3:56 pm |
N/A 2029-06-11 |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
5,000 | $0 | 147,510 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 3:56 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
5,000 | $58.74 | 147,510 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:12 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 69,293 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:12 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $54.5 | 69,293 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:11 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
500 | $70.57 | 129,311 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:11 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
3,669 | $48.43 | 129,311 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:11 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
7,188 | $67.55 | 129,311 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:11 pm |
N/A 2026-06-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Sharp Shalini CFO & Executive Vice President |
11,357 | $0 | 129,311 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 12:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
17,500 | $21 | 4,146 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 12:21 pm |
N/A 2024-07-09 |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
25,000 | $0 | 4,146 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 12:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
7,500 | $40.37 | 4,146 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 5:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,000 | $21 | 28,582 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 5:21 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,000 | $0 | 28,582 (Direct) |
View |
| 2020-07-06 Exercise |
2020-07-08 12:30 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $21 | 13,550 (Direct) |
View |
| 2020-07-06 Exercise |
2020-07-08 12:30 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $0 | 13,550 (Direct) |
View |
| 2020-07-06 Tax Withholding |
2020-07-08 12:29 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
260 | $86.75 | 23,590 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $21 | 19,731 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $0 | 19,731 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
1,500 | $21 | 31,220 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
1,500 | $0 | 31,220 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:16 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director |
6,800 | $0 | 16,550 (Direct) |
View |